Ozempic weight loss injections in London: the real picture

Why the Ozempic-for-weight-loss route has a real problem

The confusion is understandable. Semaglutide (the active ingredient in Ozempic) does produce meaningful weight loss. That's well documented, including in the STEP 1 trial published in the New England Journal of Medicine, which found around 15% average body-weight reduction over 68 weeks using semaglutide 2.4mg weekly alongside lifestyle changes. The problem is that Ozempic's licensed dose caps at 1mg (or 2mg for diabetes management), and its product licence is written for type 2 diabetes. If you want to understand how this plays out in practice, our page on weight loss injections and Ozempic sets out the clinical and regulatory picture in full. Prescribing it off-label for weight loss is legal under UK law in some narrow clinical circumstances, but it is not standard practice, it is not what NICE recommends, and it places both prescriber and patient outside the evidence base on which the medicine was approved.

The NHS's own semaglutide guidance draws this line clearly. Wegovy and Ozempic are described as separate products with different licensed purposes, not interchangeable options. A prescriber in London who reaches for Ozempic when Wegovy is available and suitable is making a choice that warrants a direct question from you.

There is also a practical concern. Ozempic has faced supply pressures partly because demand from people using it off-label for weight loss has diverted stock away from people with type 2 diabetes who depend on it. This is why the MHRA and NHS have both issued guidance urging that Ozempic be reserved for its licensed indication.

What Wegovy actually offers people looking for a semaglutide weight-loss injection

Wegovy is the version of semaglutide designed and licensed for weight management. The standard maintenance dose is 2.4mg once weekly, titrated gradually from 0.25mg over roughly four to five months — the titration schedule exists because starting at a high dose causes more nausea, and the gradual increase gives your system time to adjust. Keep the pen in the fridge door between uses; it stays stable at room temperature for a limited window when you're travelling, but the Patient Information Leaflet has the exact figures and those should guide you, not a secondary source.

In June 2026 the MHRA approved a higher 7.2mg weekly dose in a dedicated single-dose pen, broadening the options available. Trial data at 7.2mg showed average weight loss of around 20.7% over 72 weeks, which narrows the gap with tirzepatide (Mounjaro). If you want a fuller picture of how Wegovy compares with other licensed options, our weight-loss treatment overview covers the evidence side by side.

Wegovy is a prescription-only medicine. A prescriber reviews your medical history, current medications, and BMI before any prescription is issued, that step is not optional, and a legitimate service will not skip it.

How to find a legitimate weight-loss injection service rather than just a London postcode

London has no shortage of clinics advertising weight-loss injections, and not all of them are straightforward. The right question is not which one is nearest but which one is operating legally and safely. Every legitimate provider dispensing prescription medicines must be registered with the GPhC; you can check any pharmacy on the GPhC register in under a minute. If a seller cannot be found there, stop.

Red flags to know: sellers offering semaglutide injections without a consultation, clinics that do not ask for a full medical history, and anyone offering these medicines at prices far below the private market rate. The MHRA has warned publicly that counterfeit weight-loss pens are circulating in the UK supply chain, and some have contained dangerous substances. Legitimate dispensing runs through the licensed UK supply chain from authorised manufacturers.

Geography matters less than it used to. A GPhC-registered online pharmacy can review your consultation the same day and dispatch to any UK address, including anywhere in London, with next-working-day tracked delivery. If you are searching for Ozempic injections for weight loss near you, it is worth knowing that a regulated online service can be faster and safer than many local walk-in options. If you want to understand how the injection schedule for semaglutide weight-loss treatment works, that detail is worth reading before your first consultation. And if side effects are a concern, our guide to semaglutide injection side effects runs through what the evidence actually shows.

The licensed alternatives: what a UK prescriber can actually offer you

Two medicines are licensed in the UK for weight management and dispensed by registered pharmacies: Wegovy (semaglutide injection, now available up to 7.2mg) and Mounjaro (tirzepatide injection, a dual GIP and GLP-1 receptor agonist licensed up to 15mg). NICE has appraised both. Eligibility broadly requires a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea; lower BMI thresholds apply for some ethnic backgrounds under UK guidance.

A third option arrived in June 2026: the MHRA approved the first oral semaglutide tablet licensed for weight management in the UK, sold as Wegovy tablets. This is relevant for anyone who would prefer not to inject. If you'd like to explore the cost of Wegovy treatment or understand what a private prescription includes, that page gives the honest answer without varnish.

Our prescribers review consultations the same working day. If you're ready to find out which licensed treatment fits your clinical picture, speaking to our prescribers is the next step.